Cadila Healthcare gains 3% as DCGI plays phase III trials of Covid vaccine

January 4, 2021

NEW DELHI: Shares of Cadila Healthcare climbed 3 per cent in Monday's trade after the regulatory body Drugs Controller General of India (DCGI) …

Tags

January 4, 2021

Read Next

August 1, 2023

Bar codes must for top 300 medicines – Mint

February 7, 2023

'If India takes the Covid nasal vaccine, other countries will also use it': – Hindustan Times

January 22, 2023

Bharat Biotech's nasal vaccine likely to be launched on Jan 26 – Hindustan Times

January 22, 2023

First Indian intranasal Covid-19 vaccine to be launched on Jan 26 – Business Standard

December 25, 2022

Bharat Biotech's nasal vaccine debuts on CoWin, but price still to be decided | India News